Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNS
1376
DELISTED
Sapiens International
SPNS
| $8.11M | 0.01% |
565,200
-8,400
| -1% | -$118K |
|
1377
Infosys
INFY
$49.1B
| $8.09M | 0.01% |
1,090,800
-3,920,200
| -78% | -$29.4M |
|
1378
National CineMedia
NCMI
$263M
| $8.07M | 0.01% |
54,760
+1,780
| +3% | +$262K |
|
1379
Hecla Mining
HL
$12.4B
| $8.06M | 0.01% |
1,538,700
-806,953
| -34% | -$4.73M |
|
|
MN
1380
DELISTED
MANNING & NAPIER, INC.
MN
| $8.03M | 0.01% |
1,063,100
-4,800
| -0.4% | -$35.5K |
|
1381
Celestica
CLS
$42.3B
| $8M | 0.01% |
674,965
+176,777
| +35% | +$2.07M |
|
1382
Merit Medical Systems
MMSI
$5.42B
| $7.99M | 0.01% |
301,400
+24,500
| +9% | +$592K |
|
|
ULTI
1383
DELISTED
Ultimate Software Group Inc
ULTI
| $7.98M | 0.01% |
+43,748
| New | +$8.76M |
|
1384
Associated Banc-Corp
ASB
$6.09B
| $7.98M | 0.01% |
322,900
-40,179
| -11% | -$884K |
|
1385
PennyMac Financial
PFSI
$4.05B
| $7.95M | 0.01% |
477,700
+233,000
| +95% | +$3.96M |
|
1386
Murphy USA
MUSA
$10.5B
| $7.94M | 0.01% |
129,100
-94,900
| -42% | -$6.39M |
|
|
CSW
1387
CSW Industrials
CSW
$5.64B
| $7.93M | 0.01% |
215,300
+142,900
| +197% | +$4.85M |
|
|
NSA
1388
DELISTED
National Storage Affiliates Trust
NSA
| $7.9M | 0.01% |
357,900
+24,600
| +7% | +$499K |
|
|
GSS
1389
DELISTED
Golden Star Resources Ltd.
GSS
| $7.89M | 0.01% |
2,117,957
-70,840
| -3% | -$280K |
|
|
DCP
1390
DELISTED
DCP Midstream, LP
DCP
| $7.88M | 0.01% |
205,310
-166,300
| -45% | -$5.81M |
|
|
CALY
1391
Callaway Golf Company
CALY
$2.94B
| $7.86M | 0.01% |
717,400
+126,700
| +21% | +$1.44M |
|
1392
Vishay Precision Group
VPG
$955M
| $7.86M | 0.01% |
416,000
+24,900
| +6% | +$433K |
|
|
ESIO
1393
DELISTED
Electro Scientific Industries
ESIO
| $7.85M | 0.01% |
1,326,637
+87,237
| +7% | +$477K |
|
|
BECN
1394
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $7.85M | 0.01% |
170,357
+72,800
| +75% | +$3.25M |
|
1395
Madison Square Garden
MSGS
$9.88B
| $7.84M | 0.01% |
64,069
+24,112
| +60% | +$2.93M |
|
|
FRGI
1396
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $7.83M | 0.01% |
262,400
-254,266
| -49% | -$7.07M |
|
1397
Crawford & Co Class B
CRD.B
$586M
| $7.79M | 0.01% |
620,200
+85,300
| +16% | +$1.06M |
|
1398
Peoples Bancorp
PEBO
$1.48B
| $7.74M | 0.01% |
238,300
+33,500
| +16% | +$927K |
|
1399
KRONOS Worldwide
KRO
$979M
| $7.73M | 0.01% |
647,100
+419,400
| +184% | +$4.25M |
|
1400
Ryder
R
$10.1B
| $7.71M | 0.01% |
103,500
+52,200
| +102% | +$3.85M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.